Judging by comments such as
"CE Mark (EU) approval expected late 2012"
and
"CE Mark expected shortly"
it sounds like SM doesn't expect the referral to MHRA to impose a significant time barrier, considering we're already in "late 2012".
Interesting report. Thanks SM.
Add to My Watchlist
What is My Watchlist?